
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $8.2M | $13.1M | $12M | $10.8M | |
Revenue Growth (YoY) | -- | 47.87% | 59.86% | -8.35% | -10.14% | |
Cost of Revenues | -- | $1.6M | $2.9M | $2.8M | $5.1M | |
Gross Profit | -- | $6.6M | $10.2M | $9.2M | $5.7M | |
Gross Profit Margin | -- | 80.2% | 78.07% | 76.68% | 52.8% | |
R&D Expenses | -- | $26.9M | $60M | $52.8M | $49.8M | |
Selling, General & Admin | -- | $13.8M | $54M | $27.7M | $24.5M | |
Other Inc / (Exp) | -- | -$1.7M | $35M | -$3.1M | -$134.3M | |
Operating Expenses | -- | $40.7M | $113.9M | $80.5M | $74.2M | |
Operating Income | -- | -$34.1M | -$103.7M | -$71.3M | -$68.5M | |
Net Interest Expenses | -- | $2.5M | $2.9M | $703K | -- | |
EBT. Incl. Unusual Items | -- | -$38.2M | -$71.5M | -$75.1M | -$201M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$38.2M | -$71.5M | -$75.1M | -$201M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$38.2M | -$71.5M | -$75.1M | -$201M | |
Basic EPS (Cont. Ops) | -- | -$0.34 | -$0.70 | -$0.57 | -$1.09 | |
Diluted EPS (Cont. Ops) | -- | -$0.34 | -$0.70 | -$0.57 | -$1.09 | |
Weighted Average Basic Share | -- | $113.8M | $102.3M | $132M | $184.7M | |
Weighted Average Diluted Share | -- | $113.8M | $102.3M | $132M | $184.7M | |
EBITDA | -- | -$31.1M | -$59.2M | -$61.9M | -$190.8M | |
EBIT | -- | -$35.8M | -$66.2M | -$69.3M | -$197.7M | |
Revenue (Reported) | -- | $8.2M | $13.1M | $12M | $10.8M | |
Operating Income (Reported) | -- | -$34.1M | -$103.7M | -$71.3M | -$68.5M | |
Operating Income (Adjusted) | -- | -$35.8M | -$66.2M | -$69.3M | -$197.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.4M | $2.1M | $2.2M | $3.1M | $1.5M | |
Revenue Growth (YoY) | -- | -- | 4.61% | 38.66% | -51.77% | |
Cost of Revenues | -- | $414K | $510K | $1.6M | $1M | |
Gross Profit | -- | $1.7M | $1.7M | $1.5M | $442K | |
Gross Profit Margin | -- | 80.32% | 76.83% | 49.15% | 30.03% | |
R&D Expenses | -- | $13.9M | $13.7M | $11.5M | $15.5M | |
Selling, General & Admin | -- | $13M | $9M | $6.6M | $6.6M | |
Other Inc / (Exp) | -- | $8.8M | -$2.1M | -$4.2M | $62.1M | |
Operating Expenses | -- | $27M | $22.7M | $18.1M | $22.1M | |
Operating Income | -- | -$25.3M | -$21M | -$16.6M | -$21.6M | |
Net Interest Expenses | -- | $1.2M | $180K | -- | -- | |
EBT. Incl. Unusual Items | -- | -$17.6M | -$23.4M | -$20.8M | $42.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$17.6M | -$23.4M | -$20.8M | $42.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$17.6M | -$23.4M | -$20.8M | $42.6M | |
Basic EPS (Cont. Ops) | -- | -$0.33 | -$0.19 | -$0.14 | $0.15 | |
Diluted EPS (Cont. Ops) | -- | -$0.33 | -$0.19 | -$0.14 | $0.15 | |
Weighted Average Basic Share | -- | $53.7M | $124.8M | $151.9M | $284.7M | |
Weighted Average Diluted Share | -- | $53.7M | $124.8M | $151.9M | $301.6M | |
EBITDA | -- | -$15M | -$19.8M | -$17.9M | $44.4M | |
EBIT | -- | -$16.4M | -$21.9M | -$19.7M | $42.6M | |
Revenue (Reported) | $2.4M | $2.1M | $2.2M | $3.1M | $1.5M | |
Operating Income (Reported) | -- | -$25.3M | -$21M | -$16.6M | -$21.6M | |
Operating Income (Adjusted) | -- | -$16.4M | -$21.9M | -$19.7M | $42.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $13.2M | $12.9M | $9.2M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $3M | $3.8M | $4.6M | |
Gross Profit | -- | -- | $10.2M | $9M | $4.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $59.7M | $50.5M | $53.7M | |
Selling, General & Admin | -- | -- | $50M | $25.3M | $24.5M | |
Other Inc / (Exp) | -- | $8.8M | $24.1M | -$5.2M | -$68M | |
Operating Expenses | -- | -- | $109.7M | $75.9M | $78.2M | |
Operating Income | -- | -- | -$99.5M | -$66.9M | -$73.6M | |
Net Interest Expenses | -- | $1.2M | $1.8M | $507K | -- | |
EBT. Incl. Unusual Items | -- | -- | -$77.2M | -$72.5M | -$137.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -$77.2M | -$72.5M | -$137.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$77.2M | -$72.5M | -$137.6M | |
Basic EPS (Cont. Ops) | -- | -- | -$0.65 | -$0.53 | -$0.68 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.65 | -$0.53 | -$0.68 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -$64.1M | -$60M | -$128.5M | |
EBIT | -- | -- | -$71.8M | -$67.1M | -$135.4M | |
Revenue (Reported) | -- | -- | $13.2M | $12.9M | $9.2M | |
Operating Income (Reported) | -- | -- | -$99.5M | -$66.9M | -$73.6M | |
Operating Income (Adjusted) | -- | -- | -$71.8M | -$67.1M | -$135.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.8M | $2.1M | $2.2M | $3.1M | $1.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $335.5K | $414K | $510K | $1.6M | $1M | |
Gross Profit | $1.1M | $1.7M | $1.7M | $1.5M | $442K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $5.5M | $13.9M | $13.7M | $11.5M | $15.5M | |
Selling, General & Admin | $3.8M | $13M | $9M | $6.6M | $6.6M | |
Other Inc / (Exp) | -$8.2K | $8.8M | -$2.1M | -$4.2M | $62.1M | |
Operating Expenses | $9.3M | $27M | $22.7M | $18.1M | $22.1M | |
Operating Income | -$8.2M | -$25.3M | -$21M | -$16.6M | -$21.6M | |
Net Interest Expenses | -- | $1.2M | $180K | -- | -- | |
EBT. Incl. Unusual Items | -$8.2M | -$17.6M | -$23.4M | -$20.8M | $42.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$17.6M | -$23.4M | -$20.8M | $42.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$8.2M | -$17.6M | -$23.4M | -$20.8M | $42.6M | |
Basic EPS (Cont. Ops) | -$0.07 | -$0.33 | -$0.19 | -$0.14 | $0.15 | |
Diluted EPS (Cont. Ops) | -$0.07 | -$0.33 | -$0.19 | -$0.14 | $0.15 | |
Weighted Average Basic Share | $113.8M | $53.7M | $124.8M | $151.9M | $284.7M | |
Weighted Average Diluted Share | $113.8M | $53.7M | $124.8M | $151.9M | $301.6M | |
EBITDA | -$7.1M | -$15M | -$19.8M | -$17.9M | $44.4M | |
EBIT | -$8.2M | -$16.4M | -$21.9M | -$19.7M | $42.6M | |
Revenue (Reported) | $3.8M | $2.1M | $2.2M | $3.1M | $1.5M | |
Operating Income (Reported) | -$8.2M | -$25.3M | -$21M | -$16.6M | -$21.6M | |
Operating Income (Adjusted) | -$8.2M | -$16.4M | -$21.9M | -$19.7M | $42.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $11.7M | $57.9M | $21.4M | $67.7M | |
Short Term Investments | -- | -- | $84.9M | $78.5M | $124.4M | |
Accounts Receivable, Net | -- | $1.5M | $6.2M | $5M | $2.4M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | $1.9M | $3.2M | |
Other Current Assets | -- | $1.4M | $2.5M | $771K | $9.1M | |
Total Current Assets | -- | $18.1M | $154.5M | $107.7M | $206.8M | |
Property Plant And Equipment | -- | $22.5M | $48.8M | $52.1M | $52.6M | |
Long-Term Investments | -- | -- | -- | -- | $25.1M | |
Goodwill | -- | $5.4M | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | $482K | $129K | $129K | $325K | |
Total Assets | -- | $46.4M | $203.4M | $159.9M | $284.8M | |
Accounts Payable | -- | $2M | $1.9M | $5.8M | $1.6M | |
Accrued Expenses | -- | $2.6M | $5.8M | $5.2M | $7M | |
Current Portion Of Long-Term Debt | -- | $575K | $8.3M | $12.2M | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $2.3M | $2.2M | $2.2M | |
Other Current Liabilities | -- | $230K | $1.3M | $1.3M | $623K | |
Total Current Liabilities | -- | $7.6M | $21.8M | $29.1M | $11.9M | |
Long-Term Debt | -- | $24.2M | $20.6M | $9.9M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $118M | $53.2M | $50.3M | $158.2M | |
Common Stock | -- | $2K | $12K | $14K | $29K | |
Other Common Equity Adj | -- | $52K | -$161K | $244K | $105K | |
Common Equity | -- | -$71.5M | $150.2M | $109.6M | $126.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -$71.5M | $150.2M | $109.6M | $126.6M | |
Total Liabilities and Equity | -- | $46.4M | $203.4M | $159.9M | $284.8M | |
Cash and Short Terms | -- | $11.7M | $142.8M | $99.9M | $192.1M | |
Total Debt | -- | $24.8M | $28.9M | $22.1M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $206.6M | $26.1M | $35.1M | $37.2M | |
Short Term Investments | -- | -- | $95.8M | $67.7M | $172M | |
Accounts Receivable, Net | -- | $1.3M | $5.3M | $4.7M | $1.1M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | $2.1M | |
Other Current Assets | -- | $4.4M | $1.8M | $2.6M | $2M | |
Total Current Assets | -- | $215.2M | $130.3M | $110M | $214.4M | |
Property Plant And Equipment | -- | $23.9M | $51.5M | $51.9M | $53.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $5.4M | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | $1.4M | $130K | $218K | $1.1M | |
Total Assets | -- | $245.9M | $181.9M | $162.1M | $269.1M | |
Accounts Payable | -- | $3.5M | $1.7M | $3.8M | $3.4M | |
Accrued Expenses | -- | $5.2M | $8.7M | $5.9M | $5.7M | |
Current Portion Of Long-Term Debt | -- | $2.4M | $9.7M | $12.8M | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $2.4M | $2.2M | $2.2M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | $11.6M | $23M | $24.9M | $11.4M | |
Long-Term Debt | -- | $27.7M | $17.8M | $6.5M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $80.5M | $52.4M | $46.5M | $62M | |
Common Stock | -- | $11K | $12K | $16K | $29K | |
Other Common Equity Adj | -- | $61K | -$6K | $138K | -$88K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | $165.4M | $129.5M | $115.6M | $207.1M | |
Total Liabilities and Equity | -- | $245.9M | $181.9M | $162.1M | $269.1M | |
Cash and Short Terms | -- | $206.6M | $122M | $102.8M | $209.1M | |
Total Debt | -- | $30M | $27.5M | $19.3M | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$38.2M | -$71.5M | -$75.1M | -$201M | |
Depreciation & Amoritzation | -- | $4.7M | $7M | $7.4M | $6.9M | |
Stock-Based Compensation | -- | $1.8M | $44.8M | $12.4M | $13.1M | |
Change in Accounts Receivable | -- | -$1.5M | -$5.4M | $2.1M | $1.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$29M | -$62.7M | -$50.6M | -$50.6M | |
Capital Expenditures | -- | $7M | $22.7M | $9.1M | $11.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$7M | -$107M | $773K | -$78.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $27M | $5M | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$1.3M | -$8.3M | -$23.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$1.8M | $205.7M | -$107K | -$8.1M | |
Cash From Financing | -- | $25.6M | $215.5M | $13.2M | $175.5M | |
Beginning Cash (CF) | -- | $22.5M | $12M | $57.9M | $21.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$10.5M | $45.7M | -$36.6M | $46.5M | |
Ending Cash (CF) | -- | $12M | $57.9M | $21.4M | $67.7M | |
Levered Free Cash Flow | -- | -$36.1M | -$85.4M | -$59.6M | -$61.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$17.6M | -$23.4M | -$20.8M | $42.6M | |
Depreciation & Amoritzation | -- | $1.4M | $2.1M | $1.8M | $1.8M | |
Stock-Based Compensation | -- | $11.5M | $1.7M | $3M | $4.2M | |
Change in Accounts Receivable | -- | $1.8M | $431K | $657K | $2.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$15.7M | -$15.5M | -$13.1M | -$13.7M | |
Capital Expenditures | -- | $2.8M | $4.8M | $5.5M | $2.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$2.8M | -$15M | $6.2M | -$23.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $5M | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$1.8M | -$3M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $207.8M | -$107K | -$174K | $6.2M | |
Cash From Financing | -- | $213.4M | -$1.2M | $20.7M | $6.9M | |
Beginning Cash (CF) | -- | $12M | $57.9M | $21.4M | $67.7M | |
Foreign Exchange Rate Adjustment | -- | $9K | -$83K | -$85K | -$187K | |
Additions / Reductions | -- | $194.9M | -$31.7M | $13.8M | -$30.3M | |
Ending Cash (CF) | -- | $206.9M | $26.1M | $35.1M | $37.2M | |
Levered Free Cash Flow | -- | -$18.6M | -$20.4M | -$18.6M | -$16.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$77.2M | -$72.5M | -$137.6M | |
Depreciation & Amoritzation | -- | -- | $7.7M | $7.1M | $6.9M | |
Stock-Based Compensation | -- | $11.5M | $35M | $13.7M | $14.3M | |
Change in Accounts Receivable | -- | -- | -$6.7M | $2.3M | $3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -$62.5M | -$48.2M | -$51.1M | |
Capital Expenditures | -- | $2.8M | $24.7M | $9.7M | $8.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$119.2M | $22M | -$108.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$3.1M | -$9.6M | -$20.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$2.3M | -$174K | -$1.7M | |
Cash From Financing | -- | -- | $855K | $35.1M | $161.7M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -$180.8M | $8.9M | $2.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -$87.2M | -$57.9M | -$59.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$17.6M | -$23.4M | -$20.8M | $42.6M | |
Depreciation & Amoritzation | -- | $1.4M | $2.1M | $1.8M | $1.8M | |
Stock-Based Compensation | -- | $11.5M | $1.7M | $3M | $4.2M | |
Change in Accounts Receivable | -- | $1.8M | $431K | $657K | $2.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$15.7M | -$15.5M | -$13.1M | -$13.7M | |
Capital Expenditures | -- | $2.8M | $4.8M | $5.5M | $2.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$2.8M | -$15M | $6.2M | -$23.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $5M | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$1.8M | -$3M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $207.8M | -$107K | -$174K | $6.2M | |
Cash From Financing | -- | $213.4M | -$1.2M | $20.7M | $6.9M | |
Beginning Cash (CF) | -- | $12M | $57.9M | $21.4M | $67.7M | |
Foreign Exchange Rate Adjustment | -- | $9K | -$83K | -$85K | -$187K | |
Additions / Reductions | -- | $194.9M | -$31.7M | $13.8M | -$30.3M | |
Ending Cash (CF) | -- | $206.9M | $26.1M | $35.1M | $37.2M | |
Levered Free Cash Flow | -- | -$18.6M | -$20.4M | -$18.6M | -$16.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.